1. |
Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation, 2004, 110(14): e340-e437.
|
2. |
Ferraris VA, Ferraris SP, Moliterno DJ, et al. The Society of Thoracic Surgeons practice guideline series: Aspirin and other antiplatelet agents during operative coronary revascularization (executive summary). Ann Thorac Surg, 2005, 79(4): 1454-1461.
|
3. |
Shahian DM, Smith PK, Byrne JG, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 124(23): 2610-2642.
|
4. |
Sousa-Uva M, Head SJ, Milojevic M, et al. 2017 EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardio-thorac Surg, 2018, 53(1): 5-33.
|
5. |
Ferraris VA, Saha SP, Oestreich JH, et al. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drags in patients having cardiac and noncardiac operations. Ann Thorac Surg, 2012, 94(5): 1761-1781.
|
6. |
冠状动脉旁路移植术围手术期抗血小板治疗共识专家组. 冠状动脉旁路移植术围手术期抗血小板治疗专家共识. 中华胸心血管外科杂志, 2016, 32(1): 1-8.
|
7. |
Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol, 2002, 40(7): 1366-1374.
|
8. |
Tomšič A, Schotborgh MA, Manshanden JS, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment. Eur J Cardiothorac Surg, 2016, 50(5): 849-856.
|
9. |
刘培生, 陈鑫, 石开虎, 等. 术前氯吡格雷对冠状动脉旁路移植术手术效果的影响. 中华外科杂志, 2008, 46(4): 252-255.
|
10. |
郑泽, 柳景华, 黄方炯, 等. 冠状动脉旁路移植术前应用阿司匹林和氯吡格雷不同方案对近期预后的影响. 中华医学杂志, 2013, 93(38): 3060-3062.
|
11. |
Hansson EC, Jiděus L, Aberg B, et a1. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or elopidogrel: a nationwide study. Eur Heart J, 2016, 37(2): 189-197.
|
12. |
王梓, 夏利民, 宋凯, 等. 不停跳冠状动脉旁路移植术前停用阿司匹林及氯吡格雷对术后出血和输血的影响. 中华外科杂志, 2019, 57(3): 187-193.
|
13. |
Shim JK, Choi YS, Oh YJ, et al. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg, 2007, 134(1): 59-64.
|
14. |
Deja MA, Kargul T, Domaradzki W, et al. Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo, controlled, randomized trial. J Thorac Cardiovasc Surg, 2012, 144(1): 204-209.
|
15. |
Biondi-Zoccai G, Lotroionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50279 patients at risk for coronary artery disease. Eur Heart J, 2006, 27(22): 2667-2674.
|
16. |
Mihos CG, Xydas S, Williams RF, et al. Staged percutaneous coronary intervention followed by minimally invasive mitral valve surgery versus combined coronary artery bypass graft and mitral valve surgery for two-vessel coronary artery disease and moderate to severe ischemic mitral regurgitation. J Thorac Dis, 2017, 9(Suppl 7): 563-568.
|
17. |
Kizilay M, Asian Z, Vural U, et al. Is preoperative clopidogrel resistance a predictor of bleeding and risks in patients undergoing emergency CABG surgery. Braz J Cardiovasc Surg, 2018, 33(4): 330-338.
|
18. |
Ma E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in elopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv, 2012, 5(2): 261-269.
|